← Back
$AVTX All transactions

Avalo Therapeutics, Inc.

A

$ Value

$0

Shares

275,000

Price

$0

Filed

Oct 6

Insider

Name

Boyd Taylor

Title

Chief Business Officer

CIK

0002090172

Roles

Officer

Transaction Details

Transaction Date

2025-10-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

275,000

Footnotes

The stock option was granted on October 1, 2025, and vests over four years, with the first 25% vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments over the following three years, subject to the reporting person's continued employment with the Company on each applicable vesting date.

Filing Info

Accession No.

0002090172-25-000002

Form Type

4

Issuer CIK

0001534120

Boyd Taylor's History

Date Ticker Type Value
2025-10-01 AVTX A $0

Other Insiders at AVTX (90d)

Insider Bought Sold Last
KAPLAN GILLA 2026-03-28
NEIL GARRY ARTHUR
Chief Executive Officer
2026-03-28
Lind Kevin Robert 2026-03-31
Jain Rita 2026-03-31
Chan Mitchell 2026-03-28
Sullivan Christopher Ryan
Chief Financial Officer
$271K 2026-04-02
KANTOFF AARON 2026-03-28
Doyle Mittie
Chief Medical Officer
$82K 2026-04-06
Goldman Jonathan 2026-03-28
Truex Samantha 2026-03-28